Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05365607 · ClinicalTrials.gov registry record · NA
NightWare and Cardiovascular Health in Adults With PTSD
A NA study of Cardiovascular Diseases and Post Traumatic Stress Disorder, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 2
- Study locations
NCT05365607: Completed NA study of Cardiovascular Diseases and Post Traumatic Stress Disorder, sponsored by University of Colorado, Denver.
NCT05365607 is a NA study of Cardiovascular Diseases and Post Traumatic Stress Disorder that has completed, run by University of Colorado, Denver. The registered enrollment target is 40 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05365607, a NA study of Cardiovascular Diseases and Post Traumatic Stress Disorder, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine whether NightWare therapeutic intervention improves biomarkers of vascular aging and autonomic function in adults with nightmares related to PTSD.
Primary Outcome
Carotid artery compliance using carotid artery ultrasound
Conditions Studied
Interventions
- DEVICE NightWare
- DEVICE Sham NightWare
Study Locations (2)
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
- University of Colorado CCTSI CTRC - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-06-24 |
| Est. Completion | 2024-08-18 |
| Phase | NA |
What the finished NCT05365607 record still lists
NCT05365607 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower).
The record links to 6 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which NightWare is the first listed.
NCT05365607 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT05365607 about?
NCT05365607 is a clinical study titled "NightWare and Cardiovascular Health in Adults With PTSD". The purpose of this study is to determine whether NightWare therapeutic intervention improves biomarkers of vascular aging and autonomic function in adults with nightmares related to PTSD.
What is the current status of trial NCT05365607?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-06-24. Estimated completion is 2024-08-18.
What conditions does trial NCT05365607 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Post Traumatic Stress Disorder, Endothelial Dysfunction, Vascular Stiffness, Autonomic Dysfunction.
What interventions are being tested in trial NCT05365607?
The interventions under investigation include: NightWare (DEVICE), Sham NightWare (DEVICE).
Who is sponsoring clinical trial NCT05365607?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05365607 being conducted?
This trial has 2 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05365607's enrollment target sits among peer trials
40 248th of 300 higher than 49 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI